SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-005513
Filing Date
2023-08-10
Accepted
2023-08-10 16:30:48
Documents
48
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT xenetic_i10q-063023.htm   iXBRL 10-Q 580858
2 CERTIFICATION xenetic_ex3101.htm EX-31.1 10073
3 CERTIFICATION xenetic_ex3102.htm EX-31.2 10148
4 CERTIFICATION xenetic_ex3201.htm EX-32.1 4541
  Complete submission text file 0001683168-23-005513.txt   2670860

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE xbio-20230630.xsd EX-101.SCH 23528
6 XBRL CALCULATION FILE xbio-20230630_cal.xml EX-101.CAL 28641
7 XBRL DEFINITION FILE xbio-20230630_def.xml EX-101.DEF 111772
8 XBRL LABEL FILE xbio-20230630_lab.xml EX-101.LAB 170991
9 XBRL PRESENTATION FILE xbio-20230630_pre.xml EX-101.PRE 144851
42 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-063023_htm.xml XML 283903
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 231160052
SIC: 2834 Pharmaceutical Preparations